These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32330454)

  • 1. C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.
    Di Genua C; Valletta S; Buono M; Stoilova B; Sweeney C; Rodriguez-Meira A; Grover A; Drissen R; Meng Y; Beveridge R; Aboukhalil Z; Karamitros D; Belderbos ME; Bystrykh L; Thongjuea S; Vyas P; Nerlov C
    Cancer Cell; 2020 May; 37(5):690-704.e8. PubMed ID: 32330454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia.
    Ping N; Sun A; Song Y; Wang Q; Yin J; Cheng W; Xu Y; Wen L; Yao H; Ma L; Qiu H; Ruan C; Wu D; Chen S
    Leukemia; 2017 Jan; 31(1):195-202. PubMed ID: 27389056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
    Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
    Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation.
    Redondo Monte E; Leubolt G; Windisch R; Kerbs P; Dutta S; Landspersky T; Istvánffy R; Oostendorp RAJ; Chen-Wichmann L; Herold T; Cusan M; Schotta G; Wichmann C; Greif PA
    Exp Hematol; 2022 Apr; 108():26-35. PubMed ID: 35181392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.
    Schwieger M; Löhler J; Fischer M; Herwig U; Tenen DG; Stocking C
    Blood; 2004 Apr; 103(7):2744-52. PubMed ID: 14656889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation.
    Moriguchi T; Yamamoto M
    Int J Hematol; 2014 Nov; 100(5):417-24. PubMed ID: 24638828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
    Di Genua C; Nerlov C
    Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.
    Thoene S; Mandal T; Vegi NM; Quintanilla-Martinez L; Rösler R; Wiese S; Metzeler KH; Herold T; Haferlach T; Döhner K; Döhner H; Schwarzmüller L; Klingmüller U; Buske C; Rawat VPS; Feuring-Buske M
    Blood Adv; 2019 Nov; 3(22):3729-3739. PubMed ID: 31770439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
    Ohmori S; Takai J; Ishijima Y; Suzuki M; Moriguchi T; Philipsen S; Yamamoto M; Ohneda K
    Mol Cell Biol; 2012 Dec; 32(23):4742-55. PubMed ID: 22988301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
    Greif PA; Dufour A; Konstandin NP; Ksienzyk B; Zellmeier E; Tizazu B; Sturm J; Benthaus T; Herold T; Yaghmaie M; Dörge P; Hopfner KP; Hauser A; Graf A; Krebs S; Blum H; Kakadia PM; Schneider S; Hoster E; Schneider F; Stanulla M; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Blood; 2012 Jul; 120(2):395-403. PubMed ID: 22649106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation.
    Suzuki M; Kobayashi-Osaki M; Tsutsumi S; Pan X; Ohmori S; Takai J; Moriguchi T; Ohneda O; Ohneda K; Shimizu R; Kanki Y; Kodama T; Aburatani H; Yamamoto M
    Genes Cells; 2013 Nov; 18(11):921-33. PubMed ID: 23911012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells.
    Fukushima K; Matsumura I; Ezoe S; Tokunaga M; Yasumi M; Satoh Y; Shibayama H; Tanaka H; Iwama A; Kanakura Y
    J Biol Chem; 2009 Mar; 284(12):7719-32. PubMed ID: 19147501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
    Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
    Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-related hematologic disorders.
    Shimizu R; Yamamoto M
    Exp Hematol; 2016 Aug; 44(8):696-705. PubMed ID: 27235756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
    Bereshchenko O; Mancini E; Moore S; Bilbao D; Månsson R; Luc S; Grover A; Jacobsen SE; Bryder D; Nerlov C
    Cancer Cell; 2009 Nov; 16(5):390-400. PubMed ID: 19878871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.